McKnight's Long-Term Care News1d
Promising new Alzheimer’s drug candidate developed by international research team
A peptide inhibitor called RI-AG03 targets major aggregation “hot spots” of tau proteins, believed to be a key driver of ...
ScienceAlert on MSN1d
Breakthrough Alzheimer's Drug Targets Key 'Hotspots' to Suppress Toxic Tangles
The drug is RI-AG03, and it's a peptide inhibitor (a blocker of proteins). In tests on fruit flies and human cells, it has ...
Science Daily4d
Promising 'first' in Alzheimer's drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...
Neuroscience News4d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
Alzheimer’s Game Changer: Dual-Action Drug Attacks Disease at Its Core
AG03, targets two key areas of the Tau protein in Alzheimer's disease, showing effectiveness in lab and fruit fly models.
BioWorld4d
RI-AG03 targets main promoters of tau protein aggregation at once
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
Newsweek3d
Alzheimer's 'First' Achieved With Drug That Hits Hotspots
The compound, called RI-AG03, is a novel peptide inhibitor—a short chain of amino acids designed to block the activity of specific proteins. In fruit fly models and lab experiments on human ...
EuropaWire3d
Breakthrough Peptide Inhibitor Targets Tau Protein Aggregation, Paving the Way for New Alzheimer’s Treatments
An international team of researchers has made a significant breakthrough in Alzheimer's drug development with the ...
Promising Alzheimer's drug candidate prevents buildup of tau proteins in lab and fruit fly studies
An international team of researchers led by Lancaster University has made a promising breakthrough in the development of ...